GlassScriptPhysician profile
Fatime Ayoub
NPI 1669001566
$457.93
in general payments reported to CMS, 2019-2025
15 companies · $382 in 2025
The $382 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $75.57 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $457.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $87.96 | 2025 | Veozah |
| Organon LLC | $47.96 | 2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $38.70 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $37.16 | 2024-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $34.07 | 2025 | |
| Exeltis, USA INC. | $32.94 | 2024-2025 | Slynd |
| Gynesonics, INC. | $28.80 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Coopersurgical, INC. | $26.42 | 2025 | Paragard T 380a |
| Hologic Sales and Service, LLC | $22.35 | 2024 | Myosure Tissue Removal Device, Acessa Provu System |
| Pfizer INC. | $20.89 | 2025 | |
| Daiichi Sankyo INC. | $20.05 | 2025 | Injectafer |
| Shield Therapeutics INC | $18.09 | 2025 | |
| Samsung Hme America, INC. | $17.04 | 2025 | |
| Exact Sciences Corporation | $13.77 | 2025 | Cologuard Collection Kit |
| Meditrina | $11.73 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fatime Ayoub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.